Fellows and Students
Fellows and Students
Idil Oezsahin, Master student
Ms. Idil Oezsahin is a student in human medicine and master student, working on a toxicity study to determine the tolerability of two gene therapy approaches to treat neovascular and atrophic age-related macular degeneration. The objective of the project is to prepare a toxicity profile using histological, immunohistological and microscopic imaging technics.
Trong-Tin Kevin Steve Vo, Master student
Mr. Trong-Tin Kevin Steve Vo is a student in human medicine and master student, participating in two clinical studies, which aim to 1) identify biomarker patterns in multi-omic profiles from tears to better diagnose active proliferative diabetic retinopathy and 2) investigate the involvement of vasculitis in the manifestation and the severity of COVID-19.
Maximiliano Giro Larraz, Master student
Mr. Maximiliano Giro Larraz is a student in human medicine and Master student. He already performed a PREM fellowship in our group and is now working on a systematic review about the pigment epithelial-derived factor and will participate in two clinical studies scheduled to start in fall 2020.
Stéphan Tobalem, MD candidate
Dr. Stéphan Tobalem, specialist in ophthalmology and MD candidate, is trained in the handling of rodents including in vivo ocular behavioral examinations and subretinal transplantation, immunohistology, and biochemical analyses.
Dr Mateusz Kecik, MD candidate
Dr. Mateusz Kecik, ophthalmologist and MD candidate, is trained in cell culture, immunohistology, biochemical analyses, and the handling of rodents. He has been trained in the quality control of gene therapeutic medicinal products in preparation of the TargetAMD clinical trial.
Robin Verlooven, MD candidate
Dr. Robin Verlooven, resident in ophthalmology and MD candidate, is trained in cell culture, immunohistology, biochemical analyses, microbiology, molecular biology and bioinformatics. His project aims to culture ocular cells without using xenogenic supplements to improve personalized Advanced Therapy Medicinal Products (ATMP) and refine our experiments following the 3R principles.